“Together with Rospotrebnadzor, a plan was signed for a phased transition to vaccination with the tetravalent vaccine. This plan is calculated from 2019 to 2022. This year, the Russian Ministry of Health presented such a quadrivalent vaccine at the Far Eastern Economic Forum, ”RIA Novosti quoted the official as saying.
The regional noted that two domestic tetravalent flu vaccines were registered in Russia in June.
He also clarified that the tetravalent vaccine is a vaccine against two topical strains of influenza A and B.
In July, Rostec announced the successful registration in the Ministry of Health of the Russian Ultrix Quadri influenza vaccine.